查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493175

臨床試驗管理系統市場規模、佔有率、趨勢分析報告：按解決方案類型、按交付模式、按組件、按最終用戶、按地區、細分市場預測，2024-2030 年

Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type, By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗管理系統市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球臨床試驗管理系統市場規模將達到47.3億美元，2024年至2030年複合年成長率為14.65%。

臨床試驗數量的增加、虛擬和分散臨床試驗的增加以及對電子臨床解決方案的需求不斷成長推動了市場成長。

生命科學公司研發投資的增加以及急性和慢性疾病的流行正在促進旨在改善患者治療結果的臨床試驗的激增。例如，ClinicalTrials.gov 報告了 653 項正在進行的糖尿病臨床試驗，突顯了對臨床試驗管理 (CTM) 系統等解決方案的高需求，以有效管理多個臨床試驗。

多位市場參與者正在針對 DCT 及其要求推出客製化解決方案或最佳化現有解決方案。例如，Cloudbyz的分散式CTM解決方案是雲端基礎的CTM解決方案，提供ePRO、遠端監控和SDV、eConsent、eCRF、EDC、eCOA、eDiary、虛擬PR、eTMF等多種功能來支援虛擬考試。截至 2022 年，市場主要參與者 Parexel International Corporation 已進行了 250 多次完全虛擬或混合DCT，並實施了 200 多項遠距病人參與策略（例如病患招募、電子就診、保留平台）。的記錄。

臨床試驗管理系統市場報告亮點

  • 該市場的推動因素包括醫療保健 IT 的快速成長、臨床試驗數量的增加、CTMS 解決方案的日益採用以及已開發國家和新興國家政府對臨床研究的支持。
  • 按解決方案類型分類，企業細分市場在 2023 年以 74.35% 的最大收入佔有率引領市場。主要優勢包括提供偏差和應計費用的端到端洞察、強大的彙報、解決方案的擴充性、追蹤和管理監管流程以及增強的申請合規性。
  • 按組成部分來看，軟體領域在 2023 年以 56.04% 的最大收入佔有率引領市場。這是因為它是一個易於使用的工具，可以幫助您管理臨床試驗並執行關鍵功能。
  • 按交付格式分類，網路和雲端領域以 2023 年 56.04% 的最大銷售佔有率引領市場。
  • 按最終用途分類，由於合作的增加、臨床試驗外包給CRO以及臨床試驗數量的多樣化，CRO和其他細分市場在2023年佔據了最大的收益佔有率，為40.16%。
  • 北美在2023年以50.01%的收益佔有率主導市場，這得益於技術進步、該地區市場參與者的強大存在、臨床試驗領域的技術進步以及政府對促進臨床試驗的政策支持。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章臨床試驗管理系統市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 臨床試驗管理系統市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章臨床試驗管理系統市場：解決方案類型估算及趨勢分析

  • 2023 年和 2030 年解決方案類型市場佔有率
  • 細分儀表板
  • 按解決方案類型分類的全球臨床試驗管理系統市場前景
  • 說明分析
  • 公司
  • 地點

第5章臨床試驗管理系統市場：成分估計與趨勢分析

  • 2023 年及 2030 年零件市場佔有率
  • 細分儀表板
  • 全球臨床試驗管理系統市場，按組成部分的前景
  • 軟體
  • 服務

第6章 臨床試驗管理系統市場：提供模式預估及趨勢分析

  • 2023 年和 2030 年交付模式市場佔有率
  • 細分儀表板
  • 按交付模式分類的全球臨床試驗管理系統市場前景
  • 本地
  • 雲端基礎的

第7章臨床試驗管理系統市場：最終使用者估計與趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 全球臨床試驗管理系統市場應用前景展望
  • 製藥和生物技術公司
  • 醫療設備公司
  • CRO及其他

第8章臨床試驗管理系統市場：區域估計和趨勢分析，按解決方案類型、按組件、按交付模式、按最終用途

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • IQVIA, Inc.
    • Medidata（Dassault Systemes）
    • Oracle
    • DATATRAK International, Inc.
    • Clario
    • SimpleTrials
    • Calyx（formerly Parexel Informatics）
    • RealTime Software Solutions, LLC
    • Laboratory Corporation of America Holdings
    • Veeva Systems
    • Wipro Limited
    • PHARMASEAL International Ltd
Product Code: GVR-1-68038-150-4

Clinical Trials Management System Market Growth & Trends:

The global clinical trials management system market size is anticipated to reach USD 4.73 billion by 2030 and is projected to grow at a CAGR of 14.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing number of clinical trials, a rise in virtual or decentralized clinical trials, and the growing demand for eClinical solutions are some of the factors contributing to the market growth.

Life science companies' rising R&D investments and the prevalence of acute and chronic disorders contribute to the surge in clinical trials aimed at enhancing patient outcomes. For instance, ClinicalTrials.gov reports 653 active clinical trials on diabetes, indicating a significant demand for solutions like Clinical Trial Management (CTM) systems to efficiently manage multiple trials.

Several market players are launching tailored solutions or optimizing existing solutions to fit DCTs and their requirements. For example, the decentralized CTM Solution by Cloudbyz offers a cloud-based CTM solution that offers a range of features such as ePRO, remote monitoring & SDV, eConsent, eCRF, EDC, eCOA, eDiary, virtual PR, and eTMF to support virtual trials. As of 2022, Parexel International Corporation, a key player in the market, conducted over 250 fully virtual or hybrid DCTs and has experience with over 200 remote patient engagement strategies, e.g., patient recruitment, e-visits, and retention platforms, incorporated into trials.

Clinical Trials Management System Market Report Highlights:

  • The market is primarily driven by rapid growth of healthcare IT, rise in the number of clinical trials, increased adoption of CTMS solutions, and government support for clinical research in both developed & developing countries
  • Based on solution type, the enterprise segment led the market with the largest revenue share of 74.35% in 2023, owing to its key benefits, such as offering end-to-end insights into deviations & accruals, robust reporting, scalability of solutions, tracking & managing regulatory processes, and enhanced billing compliance
  • Based on component, the software segment led the market with the largest revenue share of 56.04% in 2023, due to it being an easy-to-use tool that helps manage clinical trials and perform critical functions
  • Based on delivery mode, web & cloud segment led the market with the largest revenue share of 56.04% in 2023, due to its increased adoption by end users
  • Based on end user, the CRO and others segment held the market with the largest revenue share of 40.16% in 2023, owing to the increasing number of partnerships, clinical trial outsourcing to CROs, and decentralized trial counts
  • North America dominated the market with a revenue share of 50.01% in 2023, owing to the technological advancements, strong presence of market players in the regions, technological advancement in the field of clinical trials, and supportive government policies to promote clinical trials

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Solution Type
    • 1.1.2. Component
    • 1.1.3. Delivery mode
    • 1.1.4. End user
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Solution type outlook
    • 2.2.2. Component outlook
    • 2.2.3. Delivery mode outlook
    • 2.2.4. End user outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Management System Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Clinical Trials Management System Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Clinical Trials Management System Market: Solution Type Estimates & Trend Analysis

  • 4.1. Solution Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Trials Management System Market, by Solution Type Outlook
  • 4.4. Descriptive Analysis
    • 4.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.5. Enterprise
    • 4.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.6. Site
    • 4.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Management System Market: Component Estimates & Trend Analysis

  • 5.1. Component Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Trials Management System Market, by Component Outlook
  • 5.4. Software
    • 5.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.5. Services
    • 5.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Management System Market: Delivery Mode Estimates & Trend Analysis

  • 6.1. Delivery Modes Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Trials Management System Market, by Delivery Modes Outlook
  • 6.4. On-Premises
    • 6.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 6.5. Web & Cloud-Based
    • 6.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trials Management System Market: End-user Estimates & Trend Analysis

  • 7.1. Application Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Clinical Trials Management System Market by Application Outlook
  • 7.4. Pharmaceutical and Biotechnology Firms
    • 7.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 7.5. Medical Device Firms
    • 7.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 7.6. CROs & Others
    • 7.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 8. Clinical Trials Management System Market: Regional Estimates & Trend Analysis, By Solution Type, By Component, By Delivery Mode, By End Use

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.6. Denmark
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.8. Norway
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework/ reimbursement structure
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. IQVIA, Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Medidata (Dassault Systemes)
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Oracle
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. DATATRAK International, Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Clario
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. SimpleTrials
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Calyx (formerly Parexel Informatics)
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. RealTime Software Solutions, LLC
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Laboratory Corporation of America Holdings
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Veeva Systems
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Wipro Limited
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. PHARMASEAL International Ltd
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Product benchmarking
      • 9.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 5 North America clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 6 North America clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 9 U.S. clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 12 Canada clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 17 Europe clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 18 Europe clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 19 Europe clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 21 Germany clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 22 Germany clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 23 Germany clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 24 U.K. clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 25 U.K. clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 26 U.K. clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 27 U.K. clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 29 France clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 30 France clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 31 France clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 33 Italy clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 34 Italy clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 35 Italy clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 37 Spain clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 38 Spain clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 39 Spain clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Denmark clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 41 Denmark clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 42 Denmark clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 43 Denmark clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 45 Sweden clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 46 Sweden clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 47 Sweden clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Norway clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 49 Norway clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 50 Norway clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 51 Norway clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 57 China clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 58 China clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 59 China clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 60 China clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Japan clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 62 Japan clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 63 Japan clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 64 Japan clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 65 India clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 66 India clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 67 India clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 68 India clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 69 South Korea clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 70 South Korea clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 71 South Korea clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 72 South Korea clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Australia clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 74 Australia clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 75 Australia clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 76 Australia clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Thailand clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 78 Thailand clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 79 Thailand clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 80 Thailand clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Latin America clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 82 Latin America clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 83 Latin America clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 84 Latin America clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 85 Latin America clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Brazil clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 87 Brazil clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 88 Brazil clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 89 Brazil clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Mexico clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 91 Mexico clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 92 Mexico clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 93 Mexico clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 95 Argentina clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 96 Argentina clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 97 Argentina clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 98 MEA clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 99 MEA clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 100 MEA clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 101 MEA clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 102 MEA clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 103 South Africa clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 104 South Africa clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 105 South Africa clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 106 South Africa clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 112 UAE clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 113 UAE clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 114 UAE clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 117 Kuwait clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 118 Kuwait clinical trials management system market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical trials management system market: market outlook
  • Fig. 9 Clinical trials management system competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical trials management system market driver impact
  • Fig. 15 Clinical trials management system market restraint impact
  • Fig. 16 Clinical trials management system market strategic initiatives analysis
  • Fig. 17 Clinical trials management system market: Solution type movement analysis
  • Fig. 18 Clinical trials management system market: Solution type outlook and key takeaways
  • Fig. 19 Descriptive analysis market estimates and forecast, 2018 - 2030
  • Fig. 20 Enterprise market estimates and forecast, 2018 - 2030
  • Fig. 21 Site market estimates and forecast, 2018 - 2030
  • Fig. 22 Clinical trials management system market: Component movement analysis
  • Fig. 23 Clinical trials management system market: Component outlook and key takeaways
  • Fig. 24 Software market estimates and forecast, 2018 - 2030
  • Fig. 25 Services market estimates and forecast, 2018 - 2030
  • Fig. 26 Clinical trials management system market: Delivery mode movement analysis
  • Fig. 27 Clinical trials management system market: Delivery mode outlook and key takeaways
  • Fig. 28 On-premise systems market estimates and forecast, 2018 - 2030
  • Fig. 29 Web & cloud-based systems market estimates and forecast, 2018 - 2030
  • Fig. 30 Clinical trials management system market: End user movement analysis
  • Fig. 31 Clinical trials management system market: End user outlook and key takeaways
  • Fig. 32 Pharmaceutical and biotechnology firms market estimates and forecast, 2018 - 2030
  • Fig. 33 Medical device firms market estimates and forecast, 2018 - 2030
  • Fig. 34 CROs & others market estimates and forecast, 2018 - 2030
  • Fig. 35 Global clinical trials management system market: Regional movement analysis
  • Fig. 36 Global clinical trials management system market: Regional outlook and key takeaways
  • Fig. 37 Global clinical trials management system market share and leading players
  • Fig. 38 North America market share and leading players
  • Fig. 39 Europe market share and leading players
  • Fig. 40 Asia Pacific market share and leading players
  • Fig. 41 Latin America market share and leading players
  • Fig. 42 Middle East & Africa market share and leading players
  • Fig. 43 North America: SWOT
  • Fig. 44 Europe SWOT
  • Fig. 45 Asia Pacific SWOT
  • Fig. 46 Latin America SWOT
  • Fig. 47 MEA SWOT
  • Fig. 48 North America
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030
  • Fig. 50 US
  • Fig. 51 US market estimates and forecasts, 2018 - 2030
  • Fig. 52 Canada
  • Fig. 53 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 54 Europe
  • Fig. 55 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 56 UK
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany
  • Fig. 59 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 60 France
  • Fig. 61 France market estimates and forecasts, 2018 - 2030
  • Fig. 62 Italy
  • Fig. 63 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 64 Spain
  • Fig. 65 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 66 Denmark
  • Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 68 Sweden
  • Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 70 Norway
  • Fig. 71 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 72 Asia Pacific
  • Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 74 China
  • Fig. 75 China market estimates and forecasts, 2018 - 2030
  • Fig. 76 Japan
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 78 India
  • Fig. 79 India market estimates and forecasts, 2018 - 2030
  • Fig. 80 Thailand
  • Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 82 South Korea
  • Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 86 Latin America
  • Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 88 Brazil
  • Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 90 Mexico
  • Fig. 91 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 92 Argentina
  • Fig. 93 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 94 Middle East and Africa
  • Fig. 95 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 96 South Africa
  • Fig. 97 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 98 Saudi Arabia
  • Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 100 UAE
  • Fig. 101 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 102 Kuwait
  • Fig. 103 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 104 Market share of key market players- Clinical trials management system market